REPANECT Trademark

Trademark Overview

On Thursday, November 3, 2016, a trademark application was filed for REPANECT with the United States Patent and Trademark Office. The USPTO has given the REPANECT trademark a serial number of 79200421. The federal status of this trademark filing is REGISTERED as of Tuesday, July 24, 2018. This trademark is owned by FARMA-DERMA S.R.L.. The REPANECT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations in the nature of medicinal capsules for the treatment of ulcers, wounds; antibiotic tablets for pharmaceutical purposes; plant extracts for pharmaceutical use; plant and herb extracts as components of medicated cosmetics; food supplements for medical use consisting of amino acids, minerals and/or trace elements; mineral food supplements; nutritional and food supplements; food supplements; food supplements for human consumption; medicines for human purposes, namely, for the treatment of ulcers, wounds; cough pastilles for pharmaceutical use, namely, medicated lozenges; pomades for medical purposes with wound healing properties; douching preparations for medical purposes; pharmaceutical preparations for human beings for the treatment of superficial and deep wounds; sanitary preparations for medical purpose; suppositories
repanect

General Information

Serial Number79200421
Word MarkREPANECT
Filing DateThursday, November 3, 2016
Status700 - REGISTERED
Status DateTuesday, July 24, 2018
Registration Number5521565
Registration DateTuesday, July 24, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 8, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations in the nature of medicinal capsules for the treatment of ulcers, wounds; antibiotic tablets for pharmaceutical purposes; plant extracts for pharmaceutical use; plant and herb extracts as components of medicated cosmetics; food supplements for medical use consisting of amino acids, minerals and/or trace elements; mineral food supplements; nutritional and food supplements; food supplements; food supplements for human consumption; medicines for human purposes, namely, for the treatment of ulcers, wounds; cough pastilles for pharmaceutical use, namely, medicated lozenges; pomades for medical purposes with wound healing properties; douching preparations for medical purposes; pharmaceutical preparations for human beings for the treatment of superficial and deep wounds; sanitary preparations for medical purpose; suppositories

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 23, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFARMA-DERMA S.R.L.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressIT
Party NameFARMA-DERMA S.R.L.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressIT
Party NameFARMA-DERMA S.R.L.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIT

Trademark Events

Event DateEvent Description
Monday, July 24, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, December 9, 2022NEW REPRESENTATIVE AT IB RECEIVED
Friday, November 23, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, November 6, 2018FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, November 6, 2018FINAL DISPOSITION PROCESSED
Wednesday, October 24, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 24, 2018REGISTERED-PRINCIPAL REGISTER
Friday, July 6, 2018NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, June 20, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 20, 2018NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, May 8, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 8, 2018PUBLISHED FOR OPPOSITION
Friday, May 4, 2018NOTIFICATION PROCESSED BY IB
Wednesday, April 18, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 18, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 18, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 4, 2018ELECTRONIC RECORD REVIEW COMPLETE
Friday, March 30, 2018ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Friday, March 23, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 22, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 22, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 22, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 29, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 29, 2017NON-FINAL ACTION E-MAILED
Friday, September 29, 2017NON-FINAL ACTION WRITTEN
Tuesday, August 29, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 29, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 29, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 22, 2017ASSIGNED TO LIE
Friday, July 28, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 28, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, March 11, 2017REFUSAL PROCESSED BY IB
Tuesday, February 21, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, February 21, 2017REFUSAL PROCESSED BY MPU
Friday, February 17, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, February 16, 2017NON-FINAL ACTION WRITTEN
Thursday, February 9, 2017ASSIGNED TO EXAMINER
Friday, January 27, 2017APPLICATION FILING RECEIPT MAILED
Monday, January 23, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 19, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

repanect food supplements pharmaceutical preparations medical purposes wounds treatment human extracts